Publication: Cost-effectiveness and cost-utility evaluation of individual vs. group transdiagnostic psychological treatment for emotional disorders in primary care (PsicAP-Costs): a multicentre randomized controlled trial protocol.
Loading...
Identifiers
Date
2022-01-22
Authors
Aguilera-Martin, Angel
Galvez-Lara, Mario
Cuadrado, Fatima
Moreno, Eliana
Garcia-Torres, Francisco
Vencesla, Jose F
Corpas, Jorge
Jurado-Gonzalez, Francisco J
Muñoz-Navarro, Roger
Gonzalez-Blanch, Cesar
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
BioMed Central
Abstract
Emotional disorders are common, and they have become more prevalent since the COVID-19 pandemic. Due to a high attendance burden at the specialized level, most emotional disorders in Spain are treated in primary care, where they are usually misdiagnosed and treated using psychotropic drugs. This contributes to perpetuate their illness and increase health care costs. Following the IAPT programme and the transdiagnostic approach, the PsicAP project developed a brief group transdiagnostic cognitive-behavioural therapy (tCBT) as a cost-effective alternative. However, it is not suitable for everyone; in some cases, one-on-one sessions may be more effective. The objective of the present study is to compare, in cost-benefit terms, group and individual tCBT with the treatment usually administered in Spanish primary care (TAU). A randomized, controlled, multicentre, and single-blinded trial will be performed. Adults with mild to moderate emotional disorders will be recruited and placed in one of three arms: group tCBT, individual tCBT, or TAU. Medical data and outcomes regarding emotional symptoms, disability, quality of life, and emotion regulation biases will be collected at baseline, immediately after treatment, and 6 and 12 months later. The data will be used to calculate incremental cost-effectiveness and cost-utility ratios. This trial aims to contribute to clinical practice research. The involvement of psychologists in primary care and the implementation of a stepped-care model for mental disorders are recommended. Group therapy and a transdiagnostic approach may help optimize health system resources and unblock waiting lists so that people can spend less time experiencing mental health problems. ClinicalTrials.gov: NCT04847310; Protocols.io: bx2npqde. (April 19, 2021).
Description
MeSH Terms
Adult
COVID-19
Cost-Benefit Analysis
Humans
Multicenter Studies as Topic
Pandemics
Primary Health Care
Quality of Life
Randomized Controlled Trials as Topic
SARS-CoV-2
Treatment Outcome
COVID-19
Cost-Benefit Analysis
Humans
Multicenter Studies as Topic
Pandemics
Primary Health Care
Quality of Life
Randomized Controlled Trials as Topic
SARS-CoV-2
Treatment Outcome
DeCS Terms
Análisis costo-beneficio
Atención primaria de salud
Calidad de vida
Estudios multicéntricos como asunto
Pandemias
Resultado del tratamiento
Atención primaria de salud
Calidad de vida
Estudios multicéntricos como asunto
Pandemias
Resultado del tratamiento
CIE Terms
Keywords
Anxiety disorders, Brief psychological treatments, Cost-benefit analysis, Depression, Emotional disorders, Primary care, Randomized controlled trial, Somatoform disorders, Transdiagnostic therapy
Citation
Aguilera-Martín Á, Gálvez-Lara M, Cuadrado F, Moreno E, García-Torres F, Venceslá JF, et al. Cost-effectiveness and cost-utility evaluation of individual vs. group transdiagnostic psychological treatment for emotional disorders in primary care (PsicAP-Costs): a multicentre randomized controlled trial protocol. BMC Psychiatry. 2022 Feb 9;22(1):99